Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration

Citations Over TimeTop 1% of 2015 papers

Abstract

Agents that promote tissue regeneration could be beneficial in a variety of clinical settings, such as stimulating recovery of the hematopoietic system after bone marrow transplantation. Prostaglandin PGE2, a lipid signaling molecule that supports expansion of several types of tissue stem cells, is a candidate therapeutic target for promoting tissue regeneration in vivo. Here, we show that inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), a prostaglandin-degrading enzyme, potentiates tissue regeneration in multiple organs in mice. In a chemical screen, we identify a small-molecule inhibitor of 15-PGDH (SW033291) that increases prostaglandin PGE2 levels in bone marrow and other tissues. SW033291 accelerates hematopoietic recovery in mice receiving a bone marrow transplant. The same compound also promotes tissue regeneration in mouse models of colon and liver injury. Tissues from 15-PGDH knockout mice demonstrate similar increased regenerative capacity. Thus, 15-PGDH inhibition may be a valuable therapeutic strategy for tissue regeneration in diverse clinical contexts.

Related Papers

• → Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment(2009)1,093 cited
• → Administration of Recombinant Interleukin-12 to Mice Suppresses Hematopoiesis in the Bone Marrow but Enhances Hematopoiesis in the Spleen(1995)53 cited
• Bone marrow morphology during haematopoietic stem cell mobilisation with cyclophosphamide in mice.(2003)
• Bone marrow morphology during haematopoietic stem cell mobilization with G-CSF in mice.(2004)
• [The role of the hemopoiesis-inducing microenvironment in the postradiation regeneration of hemopoiesis].(1994)